Meeting
2024 ASCO Quality Care Symposium
Hurricane disasters and radiation treatment delays among patients diagnosed with non-small cell lung cancer.
Authors
Rand Sakka
American Cancer Society, Atlanta, GA
Rand Sakka , Robin Yabroff , Fumiko Chino , Leticia M Nogueira
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Survivorship
Sub Track
Access to Treatment
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 98)
DOI
10.1200/OP.2024.20.10_suppl.98
Abstract #
98
Poster Bd #
B22
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
BRIGHTSTAR: A pilot trial of local consolidative therapy (LCT) with brigatinib in tyrosine kinase inhibitor (TKI)-naïve ALK-rearranged advanced NSCLC.
First Author: Yasir Elamin
Poster
2018 ASCO Annual Meeting
Risk of CNS adverse events (CNS-AEs) for patients with non-small cell lung cancer (NSCLC) and melanoma brain metastases (BM) treated with CNS radiation (CNS-RT) and immune checkpoint inhibitors (CPIs).
First Author: Michael Edward Devitt
Poster
2016 ASCO Annual Meeting
Nivolumab (nivo) in patients (pts) with advanced (adv) NSCLC and central nervous system (CNS) metastases (mets).
First Author: Jonathan Wade Goldman
Poster
2024 ASCO Breakthrough
Intracranial outcomes of 1L selpercatinib in advanced RET fusion-positive NSCLC: LIBRETTO-431 study.
First Author: Minji Uh